HEATHER DAVIS: Open Payments
NPI 1376530402 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 33 payments from 13 companies in 2025. Trend: 2023 $916 · 2024 $1,090 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $132 |
| Janssen Biotech, Inc. | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| ABBVIE INC. | 4 | $71 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $67 |
| Organon LLC | 2 | $66 |
| Incyte Corporation | 2 | $49 |
| Botanix SB Inc | 2 | $44 |
| Galderma Laboratories, L.P. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: Bimzelx, TREMFYA, DUPIXENT, BOTOX, OPZELURA, ILUMYA, SOFDRA, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
